⚕ GalenOps CRO console
← 710 (USA)

710-1315

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 710 (USA) (Dr. Silva) · consented 2013-02-27
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-18 (study day 112.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-06-18 (study day 112.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild HEADACHE — outcome: RECOVERED/RESOLVED; onset 2013-02-26 (study day -1.0); relationship: REMOTE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-14 (study day 77.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-05-14 (study day 77.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-18 (study day 112.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate RASH — outcome: RECOVERED/RESOLVED; onset 2013-06-18 (study day 112.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.